Invenomic Capital Management LP Lexaria Bioscience Corp. Transaction History
Invenomic Capital Management LP
- $1.73 Billion
- Q2 2025
A detailed history of Invenomic Capital Management LP transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Invenomic Capital Management LP holds 501,468 shares of LEXX stock, worth $416,218. This represents 0.03% of its overall portfolio holdings.
Number of Shares
501,468
Previous 549,947
8.82%
Holding current value
$416,218
Previous $940,000
53.62%
% of portfolio
0.03%
Previous 0.05%
Shares
15 transactions
Others Institutions Holding LEXX
# of Institutions
24Shares Held
2.4MCall Options Held
0Put Options Held
0-
Sabby Management, LLC Upper Saddle River, NJ1.17MShares$967,06925.66% of portfolio
-
Geode Capital Management, LLC Boston, MA175KShares$145,0660.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA134KShares$110,8490.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6133KShares$110,4930.0% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL44.9KShares$37,2670.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $4.94M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...